ESMO Young Oncologists: The application deadline for our 6-week Clinical Unit Visit fellowships is just around the corner: 4 April. Apply today!
There are many good reasons to become an ESMO member. Find out why you should join Europe's leading medical oncology society
ESMO’s flagship scientific journal, Annals of Oncology, publishes editorials, reviews, original articles and letters related to oncology
Our open access, online journal, ESMO Open is now listed in Pubmed Central, only 10-months after launch. Learn more about the journal!
Rossana Berardi and Ulrik Lassen describe the functionalities, the benefits and how to use the new edition of the ESMO-ASCO Global Curriculum. Produced by the European Society for Medical Oncology
29 Mar 2017
It is indicated for the maintenance treatment in adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer
28 Mar 2017
New indication concerns the treatment of adult patients with relapsed or refractory classical Hodgkin lymphoma
26 Mar 2017
It concerns the treatment of squamous cell cancer of the head and neck as monotherapy in adults progressing on or after platinum-based therapy
24 Mar 2017
First FDA-approved product for treatment of metastatic Merkel cell carcinoma
20 Mar 2017
Register now for ESMO Academy 2017! Places are limited to 250!
16 Mar 2017
It is indicated in adult and paediatric patients with refractory disease, or those who have relapsed after three or more prior lines of therapy
04 May - 06 May 2017
05 May - 08 May 2017
28 Jun - 01 Jul 2017
13 Jul - 18 Jul 2017
Oxford, United Kingdom
04 Aug - 06 Aug 2017
08 Sep - 12 Sep 2017